DocSym
β
Searchsearch
Search
(Y51.3) Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified confirmed
507 deaths with diagnosis other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
3% mortality rate associated with the disease other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
Diagnosis other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
Absence or low individual and public risk
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified - what does this mean
Other parasympatholytics, such as anticholinergics and antimuscarinics, work by blocking the action of acetylcholine, a neurotransmitter responsible for activating the parasympathetic nervous system. this can lead to inhibition of smooth muscle spasm, allowing for the relief of certain types of spasms, such as those associated with gastrointestinal and urinary tract disorders. these drugs can also be used to treat conditions such as asthma, glaucoma, and motion sickness.
What happens during the disease - other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified act by blocking the action of acetylcholine, a neurotransmitter released by the parasympathetic nervous system. this blocking action reduces the activity of the parasympathetic nervous system and reduces the amount of contractions in the smooth muscles, thereby relieving spasms and reducing the symptoms associated with it.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Urinalysis
- Blood Tests
- X-ray
- CT Scan
- MRI Scan
- Ultrasound
- Electrocardiogram (ECG)
- Bronchoscopy
- Laryngoscopy
- Gastroscopy
- Colonoscopy
- Endoscopy
- Skin Biopsy
- Tissue Biopsy
- Electromyography (EMG)
- Pulmonary Function Test (PFT)
Treatment and Medical Assistance
Main goal of the treatment: To reduce or eliminate symptoms of the disease caused by parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified.
- Prescribe medications to reduce parasympatholytic activity
- Monitor patient's response to medications
- Educate patient about lifestyle modifications to reduce symptoms
- Refer patient to physical therapy for muscle relaxation
- Refer patient to a specialist for more serious medical interventions
- Administer injections of antispasmodics
- Prescribe medications to reduce spasmolytic activity
- Perform diagnostic tests to identify underlying causes
- Administer Botox injections to reduce muscle spasms
- Provide patient with lifestyle advice to reduce stress and improve overall health
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified - Prevention
The prevention of diseases caused by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified, can be achieved through lifestyle changes, such as eating a healthy diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, avoiding exposure to environmental toxins and allergens may help reduce the risk of developing these diseases.